Cargando…
Comparison of Carboplatin With Cisplatin in Small Cell Lung Cancer in US Veterans
IMPORTANCE: The current standard of care for the treatment of small cell lung cancer (SCLC) is concurrent chemoradiation for patients with limited-stage SCLC (LS-SCLC) and chemoimmunotherapy for extensive-stage SCLC (ES-SCLC). The backbone of chemotherapy regimens in both is a platinum-etoposide dou...
Autores principales: | Azar, Ibrahim, Yazdanpanah, Omid, Jang, Hyejeong, Austin, Adam, Kim, Seongho, Chi, Jie, Alkassis, Samer, Saha, Biplab K., Chopra, Amit, Neu, Kristoffer, Mehdi, Syed, Mamdani, Hirva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585434/ https://www.ncbi.nlm.nih.gov/pubmed/36264573 http://dx.doi.org/10.1001/jamanetworkopen.2022.37699 |
Ejemplares similares
-
Rectal Invasion by Metastatic Prostate Adenocarcinoma
por: Wadehra, Anshu, et al.
Publicado: (2021) -
Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
por: Rades, Dirk, et al.
Publicado: (2023) -
Cisplatin/carboplatin cross-resistance in ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1989) -
Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer
por: Mamdani, Hirva, et al.
Publicado: (2017) -
Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?
por: Mamdani, Hirva, et al.
Publicado: (2020)